SCHEMBL23382809

SCHEMBL23382809

CC1(OC(=O)Oc2ccc(C(=O)OCC(F)(F)C(=O)O)cc2)C2CC3CC(C2)CC1C3

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 2/20 0.36
▸ CYP19A1 P11511 2/20 0.36
▸ HSD11B1 P28845 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.33
▸ MAPK1 P28482 2/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ HPGD P15428 2/20 0.32
▸ RECQL P46063 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RARA P10276 2/20 0.31
▸ RARB P10826 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ELANE P08246 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382997 0.91 CYP17A1 (0.40) CYP17A1CYP19A1HSD11B1HSP90AA1MAPK1
SCHEMBL23382707 0.88 HSD11B1 (0.36) CYP17A1CYP19A1HSD11B1HSP90AA1MAPK1
SCHEMBL23382804 0.82 RARA (0.35) CYP19A1MAPK1HIF1AHPGDKMT2A
SCHEMBL23382807 0.81 ADORA3 (0.36) CYP19A1MAPK1HIF1AHPGDKMT2A
SCHEMBL23382711 0.79 HSP90AA1 (0.36) HSD11B1HSP90AA1MAPK1HIF1AEPHX2
SCHEMBL23383038 0.78 CYP17A1 (0.34) CYP17A1CYP19A1HSD11B1MAPT
SCHEMBL23382810 0.77 SMN1; SMN2 (0.36) MAPK1HIF1AHPGDKMT2AMAPT
SCHEMBL23382811 0.77 ADORA3 (0.36) MAPK1HIF1AHPGDKMT2AMAPT
SCHEMBL23382803 0.76 ELANE (0.56) MAPK1HIF1AHPGDKMT2AMAPT
SCHEMBL14428542 0.75 CYP17A1 (0.46) CYP17A1CYP19A1HSD11B1EPHX2RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 CYP17A1 1654/4885CYP19A1 4062/4885HSD11B1 666/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 CYP17A1 1654/4885CYP19A1 4062/4885HSD11B1 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback